Prevention of Cardiovascular Disease Using a Single PolyPill in an Urban Population - Focus on Liver-Related Variables.
Status:
Completed
Trial end date:
2018-09-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to determine the effects of a fixed dose combination of
valsartan, hydrochlorothiazide, atorvastatin and aspirin (PolyPill) on prevention of
cardiovascular events in adults older than 50.
Various liver-related variables will also be recorded which will allow studying the effects
of PolyPill on the liver and the effect of liver diseases such as nonalcoholic
steatohepatitis on cardiovascular events and the protective effect of PolyPill.
Phase:
Phase 3
Details
Lead Sponsor:
Tehran University of Medical Sciences
Collaborators:
Golestan University of Medical Science University of Birmingham